Insight Molecular Diagnostics Inc. Finance Lease, Right-of-Use Asset, Amortization
Insight Molecular Diagnostics Inc. (IMDX) reported Finance Lease, Right-of-Use Asset, Amortization of $154.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-06-30 was $154.00K, a 40.00% increase year-over-year.
- Insight Molecular Diagnostics Inc. finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $155.00K, a 40.91% increase year-over-year.
- Insight Molecular Diagnostics Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $144.00K, a 41.18% increase year-over-year.
- Insight Molecular Diagnostics Inc. finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $132.00K, a 100.00% increase year-over-year.
- Insight Molecular Diagnostics Inc. finance lease, right-of-use asset, amortization for fiscal 2025 was $496.00K, a 195.24% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. finance lease, right-of-use asset, amortization for fiscal 2024 was $168.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 6 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $154.00K 10-Q · filed 2026-08-10 | $309.00K 10-Q · filed 2026-08-10 | $453.00K derived: sum of 3 quarters · filed 2026-08-10 | $585.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $155.00K 10-Q · filed 2026-05-13 | $299.00K derived: sum of 2 quarters · filed 2026-05-13 | $431.00K derived: sum of 3 quarters · filed 2026-05-13 | $541.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $276.00K derived: sum of 2 quarters · filed 2026-03-26 | $386.00K derived: sum of 3 quarters · filed 2026-08-10 | $496.00K 10-K · filed 2026-03-26 | ||
| 2025-09-30 | $132.00K 10-Q · filed 2025-11-10 | $242.00K derived: sum of 2 quarters · filed 2026-08-10 | $352.00K 10-Q · filed 2025-11-10 | $454.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $110.00K 10-Q · filed 2026-08-10 | $110.00M 10-Q · filed 2025-08-11 | $220.00K 10-Q · filed 2026-08-10 | $220.00M 10-Q · filed 2025-08-11 | $322.00K derived: sum of 3 quarters · filed 2026-08-10 | $388.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $110.00K 10-Q · filed 2026-05-13 | $110.00M 10-Q · filed 2025-05-12 | $212.00K derived: sum of 2 quarters · filed 2026-05-13 | $278.00K derived: sum of 3 quarters · filed 2026-05-13 | $278.00K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $168.00K derived: sum of 2 quarters · filed 2026-03-26 | $168.00K derived: sum of 3 quarters · filed 2026-03-26 | $168.00K 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $66.00K 10-Q · filed 2025-11-10 | $66.00K derived: sum of 2 quarters · filed 2025-11-10 | $66.00K 10-Q · filed 2025-11-10 | |||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |